GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
COUGAR BIOTECHNOLOGY (CGRB) [hlAlert]

Rating:
Buy CGRB
up 37.47 %

COUGAR BIOTECHNOLOGY (CGRB) rated Buy

Posted on: Friday,  Oct 12, 2007  11:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Buy COUGAR BIOTECHNOLOGY (NASDAQ: CGRB) on 10/12/2007, when the stock price was $31.25. Since
then, COUGAR BIOTECHNOLOGY has gained 37.47% as of 07/09/2009's recent price of $42.96.
If you would have followed this Broadpoint Capital's recommendation on CGRB, you would have gained 37.47% of your investment in 636 days.

Cougar Biotechnology, Inc. is a Los Angeles-based biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar Biotechnology is a publicly held biotechnology company established to in-license and develop early clinical stage drugs, with a specific focus on the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/12/2007 11:25 AM Buy
None
31.25 43.00
as of 10/8/2009
1 Week   
1 Month   
3 Months up  0.13 %
1 YTD up  65.42 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy